Epimab Biotherapeutics (岸迈生物) is a privately owned biopharmaceutical R&D company with a proprietary, unique, and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) that generates bispecific molecules with antibody-like properties.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.